Alamar Biosciences, Inc. (California) (ALMR)
27.52
-1.16
(-4.04%)
USD |
NASDAQ |
Nov 20, 10:21
Alamar Biosciences Free Cash Flow : -67.04M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -67.04M |
| June 30, 2026 | -64.66M |
| Date | Value |
|---|---|
| March 31, 2026 | -63.64M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Personalis, Inc. | -107.69M |
| 10X Genomics, Inc. | 93.77M |
| Champions Oncology, Inc. | -6.137M |
| Medpace Holdings, Inc. | 667.63M |
| Avantor, Inc. | 439.20M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -14.73M |
| Cash from Investing (Quarterly) | 11.74M |
| Cash from Financing (Quarterly) | -9.849M |
| Free Cash Flow Per Share (Quarterly) | -0.2213 |
| Free Cash Flow to Equity (Quarterly) | -6.318M |
| Free Cash Flow to Firm (Quarterly) | -15.22M |
| Free Cash Flow Yield | -3.51% |